Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Hair loss linked to prostate enlargement; stress and family history important factors.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Six new genetic regions linked to early hair loss also connect to Parkinson's disease and prostate cancer, possibly leading to new treatments.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

The document covers various male health issues, their causes, treatments, and related conditions.

Spironolactone treatment increases the amount of testosterone available in the body.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.